Roche to present new data on OCREVUS in multiple sclerosis and ENSPRYNG in neuromyelitis optica spectrum disorder at ECTRIMS 2021

NEXT STORY
Orion publishes Interim Report for January–September 2021 on Wednesday 20 October 2021
PREV STORY
First Patient Dosed in Phase II Study of TLX250-CDx in Triple-Negative Breast Cancer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

MediciNova Announces Presentation Regarding Clinical Trial of MN-166 (ibudilast) in ALS at the 6th Annual California ALS Pac10 and Research Network Meeting at UCSD, La Jolla, California　

LA JOLLA, Calif., Dec. 06, 2015 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company ...

author_avatar
NASDAQ Market News

Global Amniotic Membrane Market to Surpass US$ 7,438.2 Million by 2028; inorganic activities such as collaborations and acquisitions to Augment Growth, Says Coherent Market Insights (CMI)

author_avatar
NASDAQ Market News

Fortress Biotech Announces Pricing of Series A Preferred Stock Offering

author_avatar
NASDAQ Market News